Aristolochic acid C [4849-90-5]
Cat# TN1064-10mg
Size : 10mg
Brand : TargetMol
Contact local distributor :
Phone : +1 850 650 7790
Aristolochic acid C
Copy Product Info
Aristolochic acid C, a derivative of Aristolochic acid, acts as a phospholipase A2 inhibitor.
Cas No. 4849-90-5
For research use only—not for human use. No sales to individuals. Use as intended only.
Select Batch
Purity:99.8%
Appearance:Solid
Color:Orange
COA LCMS
Product Introduction
Aristolochic acid C AI Summary
Aristolochic acid C exhibits a bioactivity of inhibiting CDK2 with an IC50 value of 30,000 nM. Additionally, it shows anti-inflammatory activity in human neutrophils by inhibiting fMLP/CB-induced superoxide anion generation and elastase release after 5 minutes, with an IC50 value greater than 10.0 µg/mL, indicating moderate to weak inhibitory activity at this concentration..
Note: Summary generated by AI. Data source: ChEMBL 
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Aristolochic acid C, a derivative of Aristolochic acid, acts as a phospholipase A2 inhibitor. |
| Molecular Weight | 327.25 |
| Formula | C16H9NO7 |
| Cas No. | 4849-90-5 |
| Smiles | OC(=O)c1cc2OCOc2c2c3cc(O)ccc3cc([N+]([O-])=O)c12 |
| Relative Density. | 1.707 g/cm3 |
| Storage | Keep away from direct sunlight,Keep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 125 mg/mL (381.97 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (12.22 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||